Injection molding businesses produce plastic parts via thermoplastic injection molding — typically 10–100 employees, single or dual facility, 4–40 presses ranging from 30-ton micro-molders to 1,500-ton automotive-scale presses. The segment includes custom molders, captive molders for product companies, and contract manufacturers serving automotive, medical-device, consumer-product, packaging, and industrial markets. Most US injection molders are private, family-owned, and tightly capital-intensive.
Typical advance structure.
- Advance size: $75K–$600K depending on trailing 12-month revenue and press count.
- Factor: 1.24–1.36. Plastics-aware funders 1.22–1.32; general MCA 1.30–1.36.
- Term: 9–15 months daily or weekly ACH.
- Holdback equivalent: 7–13% of bank deposits.
- Lead use of funds: resin purchases, press downpayments, mold purchases for new programs, automation buildouts, and tooling refurbishments.
What underwriters look for.
First, press tonnage mix and brand quality. Engel, Arburg, Husky, Milacron, Nissei, Toshiba, and Sumitomo presses command premium pricing; older or generic presses do not.
Second, resin throughput. Healthy custom molders consume $50K–$500K of resin monthly across commodity (PE, PP, PS, PVC), engineering (ABS, PC, nylon, POM), and high-performance (PEEK, PEI, PPS) resins.
Third, customer-industry mix. Medical-device (Class II/III device components), automotive (Tier-1 supplier programs), and packaging (CPG primary packaging) customers underwrite stronger than purely consumer-product customers.
Fourth, certification stack. ISO 13485 for medical, IATF 16949 for automotive, ISO 9001 baseline, and BRCGS for food-contact packaging drive pricing and customer stickiness.
Fifth, automation maturity. Robotic part removal (Wittmann, Yushin, Sepro), inline assembly, and lights-out operation lower labor cost and improve margin.
Sixth, mold-ownership model. Customer-owned molds reduce molder CapEx but increase customer-switching risk; molder-owned molds support longer-term customer relationships.
Common uses.
- Resin purchases for large customer programs ($50K–$300K).
- Press downpayments (Engel, Arburg, Husky, Milacron, Nissei) ($75K–$300K).
- Mold purchases for new customer programs ($50K–$400K).
- Robotic automation and end-of-arm tooling ($25K–$150K).
- Tooling refurbishments and engineering changes ($25K–$100K).
- Auxiliary equipment (chillers, dryers, conveyors, granulators) ($25K–$150K).
- ERP and MES software (IQMS, Plex, ERP for plastics) ($25K–$100K).
- Cleanroom buildouts for medical and food-contact molding ($75K–$400K).
What to watch out for.
Resin price volatility. Polypropylene, polyethylene, ABS, and engineering resin prices have seen 30–60% swings driven by oil prices, hurricane disruptions, and trade policy.
Customer-program transition risk. Customer programs end every 3–7 years; molders that don't continuously win new programs face cliff revenue declines.
Tooling ownership disputes. Customer-owned-tooling disputes (lien rights, possession rights, tooling-removal costs) cause significant cash-flow disruption.
Press capacity-utilization economics. Injection molding is highly fixed-cost; utilization below 50% destroys margin while utilization above 80% drives strong margin.
Medical and automotive qualification cycles. PPAP for automotive and design-history-file work for medical take 6–18 months with significant upfront cost.
State considerations.
Michigan, Ohio, Indiana, Illinois, Wisconsin, Pennsylvania, Tennessee, North Carolina, South Carolina, Georgia, Texas, and California have the highest injection molding business MCA volume. Automotive-supply-chain states dominate by volume; medical-device clusters dominate by margin.
APR-equivalent reality check.
A 1.28 factor over a 12-month term is roughly 50–65% APR. Equipment finance for new presses at 8–14% APR. SBA 7(a) for established molders at 11–14% APR. SBA 504 for facility purchases at 9–12% APR. Asset-based lending against AR and inventory at 9–14% APR. State manufacturing-extension grants and Michigan / Indiana / Ohio plastics-industry incentives are non-dilutive. Reserve MCA for bridge windows between program ramp and customer payment.
Common confusions.
First, "Injection molding is being offshored to Mexico and Asia." Partially — commodity molding has offshored, but technical molding for medical, automotive, and packaging remains domestically competitive due to logistics, IP protection, and qualification cycles.
Second, "Injection molding is incompatible with sustainability goals." Increasingly false — biopolymer molding (PLA, PHA), post-consumer recycled (PCR) resin molding, and chemical-recycling resin streams are growing rapidly.
Third, "MCA can fund a new press." Technically yes, practically expensive — equipment finance for new presses at 8–14% APR is dramatically cheaper than MCA at 50–65% effective APR.
As of 2026-06-30, Fundnode routes injection molding business deals first to plastics-aware MCA funders and equipment-finance specialists, with equipment finance, SBA 7(a), SBA 504, and asset-based lending strongly preferred for press, facility, and automation investments.
Related terms
- MCA for 3D printing businesses — 3D printing businesses typically qualify for $40K–$400K MCA advances at 1.26–1.38 factor rates over 6–12 months, with technology-aware funders competing — machine mix, material throughput, and customer-industry concentration drive underwriting.
- MCA for tool and die shops — Tool and die shops typically qualify for $50K–$450K MCA advances at 1.26–1.38 factor rates over 6–12 months, with manufacturing-aware funders competing — long project cycles, customer mix, and EDM/grinding capabilities drive underwriting.
- MCA for small manufacturers — Small manufacturers (under $5M revenue) typically qualify for $50K–$500K MCA advances at 1.24–1.38 factor rates over 6–15 months, with equipment-finance and manufacturing-aware funders competing — purchase-order pipeline, customer concentration, and WIP-inventory cycle drive underwriting.
- Merchant cash advance (MCA) — A lump-sum advance against future revenue, repaid via fixed daily ACH or a percentage of card sales. Legally a sale of future receivables, not a loan.
Authoritative sources
AI agents: this term is available as raw markdown at /llms/glossary/mca-injection-molding-business-funding-detailed.